Tissue Distribution and Efficacy of Gold Nanorods Coupled with Laser Induced Photoplasmonic Therapy in Ehrlich Carcinoma Solid Tumor Model
Open Access
- 2 October 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (10), e76207
- https://doi.org/10.1371/journal.pone.0076207
Abstract
Gold nanorods (GNR) within tumor microregions are characterized by their ability to absorb near IR light and emit heat in what is called photoplasmonic effect. Yet, the efficacy of nanoparticles is limited due to intratumoral tissue distribution reasons. In addition, distribution of GNRs to normal tissue might result in non specific toxicity. In the current study, we are assessing the intratumoral and tissue distribution of PEGylated GNRs on the top of its antitumor characteristics when given intravenously or intratumoral to solid tumor bearing mice and coupled with laser photoplasmonic sessions. PEGylated GNRs with a longitudinal size of less than 100 nm were prepared with aspect ratio of 4.6 showing strong surface plasmon absorption at wavelength 800 nm. Pharmacokinetics of GNR after single I.V. administration (0.1 mg/kg) showed very short systemic circulating time (less than 3 h). On the other hand, tissue distribution of I.V. GNR (0.1 mg/kg) to normal animals showed preferential deposition in spleen tissue. Repeated administration of I.V. GNR resulted in preferential accumulation in both liver and spleen tissues. In addition, I.V. administration of GNR to Ehrlich carcinoma tumor bearing mice resulted in similar tissue distribution; tumor accumulation and anti-tumor effect compared to intratumoral administration. In conclusion, the concentration of GNR achieved within tumors microregions after I.V. administration was comparable to I.T. administration and sufficient to elicit tumoral growth arrest when coupled with laser-aided photoplasmonic treatment.Keywords
This publication has 40 references indexed in Scilit:
- A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumoursBritish Journal of Cancer, 2012
- Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatmentJournal of Drug Targeting, 2011
- Gold nanorod mediated plasmonic photothermal therapy: A tool to enhance macromolecular deliveryInternational Journal of Pharmaceutics, 2011
- Optimizing the formation of biocompatible gold nanorods for cancer research: Functionalization, stabilization and purificationJournal of Colloid and Interface Science, 2011
- Controlled-release system of single-stranded DNA triggered by the photothermal effect of gold nanorods and its in vivo applicationBioorganic & Medicinal Chemistry, 2011
- Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophagesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Controlled release of PEG chain from gold nanorods: Targeted delivery to tumorBioorganic & Medicinal Chemistry, 2010
- Advances and Prospects of Gold NanorodsChemistry – An Asian Journal, 2008
- Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in miceCancer Letters, 2008
- Hyperthermic Effects of Gold Nanorods on Tumor CellsNanomedicine, 2007